Serial urinary neopterin :creatinine ratios of 58 healthy adult sub jects were measured from 2 days prior t o and up to 12 days post vaccination. An increase in the urinary neopterin of at least twice the baseline was detected in 24/ 46 subjects who received either a Mantoux skin test or a live viral vaccine (cell mediated immune group, median average increase above baseline = 206%(interqllarTikr.lIge 150'33H%» ), and 'in 5/12 who received non-live vaccines known to stimulate mainly humoral immunity ( humoral immune g roup, median average increase above baseline = 165%(intcrQIl.rlik ranse 142412%) )' The peaks in the urinary neopterin in the cell mediated group occurred between days 5 and 10 post-vaccination, with the mode on day 5. In contrast the 5 subjects in the humoral immune group all developed their peaks on day 7 or 8 . Three of these subjects received an influenza vaccine, one a typhoid vaccine and one a tetanus toxoid. No association was fC 1llnd betwee n local or systemic side-effects of vaccination and raised urinary neopterin . In conclusion, the monitoring of urinary neopterin excretion in adults is sensitive enough to detect an immunological response to vaccination with immunogens that induce either cell mediated or humoral immune responses.
Introduction
Neopterin is a relatively stable product of interferon gamma (INF-(y) induced macrophage activity and is an indirect measure of both I}"TF-y levels and macrophage activit), ( 1 ) . It is produced almost exclusivc\y by m acrophages, due to a functio nal block in the pathway synthesising tetrahydrobiopterin (2) , an essential co-factor for the inducible form of nitric oxide synthase (3, 4) . Neopterin's role as a surrogate marker of inflammation h as been well studied in infections (particularly HIV), malignancies, autoimmunity and transplan- § Author to whom correspondence should be addressed.
Pteridines/ Vol. 7 / No. 3 tation( l ). To determine how sensltlve neopterin is as a marker of inflammation in adults, we measured serial neopterin excretio n in a group of adult subjects w1dergoing various vaccinations or Mantoux testing with tuberculin purified protein derivative (PPD ).
Materials and Methods
Fifty eight healthy adults who were either receiving a vaccination or undergoing a Mantoux skin test with tu berculin PPD were included in the study. T hey were divided into two groups depending on whether the predominant immunological stimulus was cell mediated or humoral.
Forty five subjects undergoing Mantoux skin test with tuberculin PPD (Evans Medical) and one subject who had a live rubella vaccine (Evans Medical) constituted the cell-mediated immune (CMI) group. Twelve subjects undergoing vaccination with non-live vaccines were included ill the humoral immune group. These latter vaccinations included 5 influenza (Fluvirin iE , Evans Medical), 2 hepatitis B (Engerix B®, SmithKline Beecham), 2 typhoid (Typhim Vi®, Pasteur Merieux, 1 hepatitis A. (Havrix®, SmithKline Beecham) and 2 tetanus toxoid (Wellcome). A disproportionately large number of patients undergoing Mantoux skin tests were recruited, to allow us to compare differences in subJects with positive or negative skin reactions. Subjects were instructed to collect daily urine specimens starting 2 days prior to and finishing 10 to 12 davs after the vaccination or skin test. As urinary neopterin excretion has a normal diurnal variation 5), we elected to collect the first specimen of the day. Urine was collected in small polypropylene tubes, labelled and immediately home frozen in a Light-proof container to prevent spontaneous degradation of neopterin from exposure to light. Patients \\ere also instructed to keep a detailed daily diary documenting and describing any local or systemic side-effects to the vaccination as well as any intections during the study period.
To correct for the variable concentration of urine, the neopterin concentration is expressed as a ratio to creatinine . Both neopterin and creatinine were measured by high pressure liquid chromatography (HPLC) (6) . Due to a smaller muscle mass and lower creatinine excretion, females have on average a 20% higher urinary neopterin:creatinine ratios than males, therefore all urinary neopterin levels on females subjects were divided by a factor of 1.2 to correct for this. This correction tactor was ' obtained from data collected on 40 control subjects (data not shown ) which corresponds to that published in the literature ( 1) .
A baseline threshold was established for each subject by taking the mean of the urinary neopterin tram days 2 pre to day 3 post-vaccination inclusive. Subjects were only considered to have a significant increase in their neopterin excretion if at least one urinary neopterin after day 3 was more than double their calculated baseline threshold. A time course plot was then generated for each group by plotting the mean daily corrected urinary neopterin against time. Peaks were identitied and only considered significant if their peak height was at least double that of the baseline. Data was compared using the Student T, Wallis, Chi-squared and Fisher Exact tests as appropriate. A p-value of less than 0.05 was considered significant .
Results
The mean ages of the cell mediated and humoral immune groups were 36.6± 11.6 years and 42.0± 13 .3 years respectively. Twenty six out of 46 subjects in the CMI and 10/12 in the humoral immune group were females. These differences are not significant.
Post-vaccination, most subjects had an increase in their urinary neopterin ( fig. 1 ) . The cell mediated group had a median average increase of 206% (int«quartile range 150 .308 %), in their peak urinary neopterin from a median baseline of 138 J.lmoljmol (interquartile range 94-209) to a median peak of 232 J.lmol/mol(interquartile range 1 70 . 338 ), and the humoral group a median average increase of 165%(inrerquartik range 14H1 2%) from a median baseline of 124 J.lmol/ mol (interquartile range 92-182) to a median peak of 227 J.lmoljmol (interquartile range 140-404 ). Only 24/46 (52%) subjects in the CMI group and 5/ 12 (42%) subjects in the humoral immune group had clear peaks in their urinary neopterin ( fig. 1) as defined above. In the CMI group, the maximum levels were all detected from day 5 to 10 post skin test, with the mode on day 5. In contrast the 5 subjects in the humoral immune group all developed their peaks on day 7 or 8 . Three of the latter subjects received influenza vaccines, one a typhoid vaccine, and one a tetanus toxoid.
Eighteen out of 45 subjects receiving Mantoux skin tests had had a previous BCG vaccination, and no patient had a previous history of tuberculosis. Eight out of 18 subjects (44% ) who had previously had a BCG vaccination developed clearly defined peaks in response to PPD, compared to 15/ 27 subjects (56%) who had not had a previous BCG vaccination (p = n .s.). The former patients tended to have a lower median uriniary neopterin peak than the latter patients (179 J.lmolj mol(interquartilc range 160-288 ) , vs . 248 J.lmol/ mol(int<tquartilc range 184 ':148» P = 0.07 ). All Mantoux skin tests were read at 48 hours and considered positive if the diameters in two planes were greater than 5 mm. Nineteen skin tests were negative and 26 positive. Eleven out of 19 ( 58%) subjects with a negative Mantoux skin test, compared to onl\' 10/ 26 ( 38% ) subjects with a positi\-e .\lantoux skin tcst, had a peak in their urinary neoptcrin as defined above (p = n.s. ). The suhjects \\'irh ncgativc Mantoux skin tests tended to have higher median peak urinary neopterin levels (257 j.lmol/moIC irlterquartile range 170-360J, than subjects with positive Mantoux skin tests ( 198 j.lmol/ moIC inte<quartile range 165 -288) , P = n.s. ).
No association was found between the local or systemic . side-effects of vaccination and raised neopterin levels. Thirty one patients documented local reactions of pain, swelling or erythema due to vaccination. Their average median peak urinary neopterin from day 5 to 10 was slightly lower than patients without local reactions, but did not reach statistical significance (205 j.lmol!moICinterquartile range 163 313 ), vs. 256 j.lmol/mo~interquartile range 17 3-354» P = n.s.) .
Similarly 31 subjects who complained of mild systemic symptoms like fever, myalgias, headache and tiredness due to the vaccination, tended to have an average median peak urinary neopterin level that was lower than the 27 subjects without systemic reactions (201 j.lmol/moIC interquartile range 165-3 13), vs. 258 j.lmol/moIC interquartile range 169-360), p = n.s.) .
The average time course plots for the eMI and
... humoral immune groups are presented in figs 2a and 2b respectively. In the eMI group a clear peak occurred between days 4 and 10, with the maximum height on day 5 . The mean area under the graph from days 4 to 9 post-vaccination was significantly greater than the area under the graph from days 2 pre-to day 3 post-vaccination (p = O. 009). In the humoral immune group the post-vaccination peak is noted on day 8, with the area under the curve from days 4 to 9 being statistically greater than the area under the curve graph from days 2 pre-to day 3 post-vaccination (p = 0.04).
Discussion
In contrast to Wildgrube, et al (7) who were unable to demonstrate increased neopterin production in response to various skin tests in 25 subjects, we have shown that neopterin is sensitive enough in adult subjects to detect the eMI response to low dose PPD as well as vaccines known to stimulate a humoral response. Fuchs et al (8) . have demonstrated previously that the vaccination of 4 children with live measles/mumps vaccine induced a marked and brisk increase in neopterin excretion that peaked between day 8 and day 11. This time course was similar to the 5 subjects in the humoral group but differed from subjects in the ceU mediated group, who tended to have an earlier peak between day 4 and day S . This difference in time courses is probably related to the fact that the immune response in the 4 paediatric cases and subjects in our humoral group was a primary response to a new set of antigens. This would therefore be delayed compared to a secondary response to a previously recognised set of antigens, like PPD in the CMI group. It is worth noting that children have higher baseline urinary neopterin than adults( l ). The peak urinary neopterin (1000-2000 J..lmol neopterin/mol creatinine) found by Fuchs et aleS) in their 4 paediatric subjects are higher than those in our CMI group (± 350 Ilmol neopterin/ mol creatinine). This may reflect the baseline differences between children and adults.
Surprisingly, 3 subjects receiving influenza vaccine, 1 a typhoid and 1 a tetanus toxoid booster had an increase in their urinary neopterin . Although the primary aim of these vaccines is to induce a good humoral IgG response which depends on the Th2 cytokine IL-4, some IFN-y is also produced. It therefore seems highly unlikely that the Thl and Th2 pathways are mutually ex--.:Iusive in vaccination, and the various contributions of the Thl and Th2 pathways to a specdic set of antigens depends on other factors that are probably host-related.
A striking and very interesting observation is the elevated level of neopterin production in subjects who have negative skin reactions to PPD. These subjects are able to generate a systemic response that is unaccompanied by a positive skin reaction. These patients may have low or absent circulating memory T-cells to PPD, and when exposed to the antigen they mount a more vigorous primary immune response. In contrast the patients with positive skin reactions have a good pool of circulating memory T -cells and are able to localise the immune reaction to the site of inoculation as a secondary immunological response. Against this suggestion is the similar time course of neopterin production in patients without and with positive skin reactions, as one would expect the neopterin production of a primary immunological response to be delayed relative a secondary one . Another possibility is that PPD contains sufficient quantities of mycobacterial heat shock proteins, which can activate large numbers of T-cells non-specifically as superantigens (9) , resulting in systemic IFN-y production.
The time course of peak neopterin excretion in 85 response to PPD is compatible with the time course of local IFN-y production. Using immunohistochemistry of PPD induced skin lesions, the maximum local production of IFN-y was detected at 48 hours( lO) compared to day 5 for neopterin production in this study. This 72 hour delay in peak neopterin production from that of local IFN -y production is equivalent to that found in vitro, using stimulated macrophages(ll).
The purpose of undertaking this study was not to determine the different immunological responses to various antigens, but to see how sensitive neopterin is as an immunological marker. Our results show that urinary neopterin excretion, although non-specific, is a very sensitive marker. Monitoring urinary neopterin excretion is therefore capable of detecting minor degrees of inflammation, of the order of magnitude associated with vaccinations or immunological skin tests.
